{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:10:13Z","timestamp":1789729813242,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0663-1","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T08:56:39Z","timestamp":1442825799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HMGB1\/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients"],"prefix":"10.1186","volume":"13","author":[{"given":"JooYeon","family":"Jhun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeungHoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HeeYeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Mi","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"issue":"10","key":"663_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00002512-200118100-00002","volume":"18","author":"P Merle","year":"2001","unstructured":"Merle P, Trepo C, Zoulim F. Current management strategies for hepatitis B in the elderly. Drugs Aging. 2001;18(10):725\u201335.","journal-title":"Drugs Aging"},{"issue":"11","key":"663_CR2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 2004;350(11):1118\u201329.","journal-title":"N Engl J Med"},{"issue":"6","key":"663_CR3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","volume":"57","author":"R Jalan","year":"2012","unstructured":"Jalan R, et al. Acute-on chronic liver failure. J Hepatol. 2012;57(6):1336\u201348.","journal-title":"J Hepatol"},{"issue":"3","key":"663_CR4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2249.1998.00534.x","volume":"111","author":"T Hohler","year":"1998","unstructured":"Hohler T, et al. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 1998;111(3):579\u201382.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"663_CR5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","volume":"50","author":"M Hosel","year":"2009","unstructured":"Hosel M, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50(6):1773\u201382.","journal-title":"Hepatology"},{"issue":"5425","key":"663_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248\u201351.","journal-title":"Science"},{"issue":"1","key":"663_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.25982","volume":"57","author":"X Wang","year":"2013","unstructured":"Wang X, et al. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of gammadelta T cells with macrophages. Hepatology. 2013;57(1):373\u201384.","journal-title":"Hepatology"},{"issue":"11","key":"663_CR8","first-page":"812","volume":"15","author":"HB Liu","year":"2007","unstructured":"Liu HB, et al. Serum level of HMGB1 in patients with hepatitis B and its clinical significance. Zhonghua Gan Zang Bing Za Zhi. 2007;15(11):812\u20135.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"663_CR9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.7314\/APJCP.2012.13.4.1365","volume":"13","author":"Q He","year":"2012","unstructured":"He Q, et al. HMGB1 promotes the synthesis of pro-IL-1beta and pro-IL-18 by activation of p38 MAPK and NF-kappaB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev. 2012;13(4):1365\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"663_CR10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/onc.2012.631","volume":"33","author":"R Kang","year":"2014","unstructured":"Kang R, et al. The HMGB1\/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene. 2014;33(5):567\u201377.","journal-title":"Oncogene"},{"issue":"6","key":"663_CR11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2337\/diabetes.50.6.1495","volume":"50","author":"CH Yeh","year":"2001","unstructured":"Yeh CH, et al. Requirement for p38 and p44\/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes. 2001;50(6):1495\u2013504.","journal-title":"Diabetes"},{"issue":"2","key":"663_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0625.2011.01408.x","volume":"21","author":"P Zhu","year":"2012","unstructured":"Zhu P, et al. Involvement of RAGE, MAPK and NF-kappaB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol. 2012;21(2):123\u20139.","journal-title":"Exp Dermatol"},{"issue":"5","key":"663_CR13","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.4049\/jimmunol.0903133","volume":"184","author":"S Xie","year":"2010","unstructured":"Xie S, et al. IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. J Immunol. 2010;184(5):2289\u201396.","journal-title":"J Immunol"},{"issue":"8","key":"663_CR14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.mca.0000236288.94553.b4","volume":"17","author":"S Hashmi","year":"2006","unstructured":"Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis. 2006;17(8):699\u2013706.","journal-title":"Coron Artery Dis"},{"issue":"2","key":"663_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-007-8014-9","volume":"41","author":"Z Chen","year":"2008","unstructured":"Chen Z, O\u2019Shea JJ. Th17 cells: a new fate for differentiating helper T cells. Immunol Res. 2008;41(2):87\u2013102.","journal-title":"Immunol Res"},{"issue":"9","key":"663_CR16","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.4049\/jimmunol.181.9.6117","volume":"181","author":"C Song","year":"2008","unstructured":"Song C, et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol. 2008;181(9):6117\u201324.","journal-title":"J Immunol"},{"issue":"1","key":"663_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","volume":"51","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81\u201391.","journal-title":"Hepatology"},{"issue":"2","key":"663_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/liv.12268","volume":"34","author":"GL Zhang","year":"2014","unstructured":"Zhang GL, et al. High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV. Liver Int. 2014;34(2):266\u201373.","journal-title":"Liver Int"},{"key":"663_CR19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1746-1596-8-40","volume":"8","author":"WJ Du","year":"2013","unstructured":"Du WJ, et al. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection. Diagn Pathol. 2013;8:40.","journal-title":"Diagn Pathol"},{"issue":"5","key":"663_CR20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431\u20135.","journal-title":"Hepatology"},{"issue":"5","key":"663_CR21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.gde.2005.08.007","volume":"15","author":"ME Bianchi","year":"2005","unstructured":"Bianchi ME, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev. 2005;15(5):496\u2013506.","journal-title":"Curr Opin Genet Dev"},{"issue":"7\u20138","key":"663_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","volume":"14","author":"JR Klune","year":"2008","unstructured":"Klune JR, et al. HMGB1: endogenous danger signaling. Mol Med. 2008;14(7\u20138):476\u201384.","journal-title":"Mol Med"},{"key":"663_CR23","first-page":"596","volume":"2013","author":"ZW He","year":"2013","unstructured":"He ZW, et al. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-kappaB signaling pathways. Mediat Inflamm. 2013;2013:596\u2013716.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"663_CR24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/lt.22306","volume":"17","author":"G Basta","year":"2011","unstructured":"Basta G, et al. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? Liver Transpl. 2011;17(6):633\u201340.","journal-title":"Liver Transpl"},{"issue":"11","key":"663_CR25","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.4049\/jimmunol.181.11.7473","volume":"181","author":"T Nagata","year":"2008","unstructured":"Nagata T, et al. Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol. 2008;181(11):7473\u20139.","journal-title":"J Immunol"},{"key":"663_CR26","doi-asserted-by":"crossref","unstructured":"Lafdil F, et al. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology. 2009;137(6): 2125\u201335 e1\u20132.","DOI":"10.1053\/j.gastro.2009.08.004"},{"issue":"7","key":"663_CR27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20042614","volume":"201","author":"A Tsung","year":"2005","unstructured":"Tsung A, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201(7):1135\u201343.","journal-title":"J Exp Med"},{"issue":"1","key":"663_CR28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.26395","volume":"58","author":"T Pusterla","year":"2013","unstructured":"Pusterla T, et al. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. Hepatology. 2013;58(1):363\u201373.","journal-title":"Hepatology"},{"key":"663_CR29","doi-asserted-by":"crossref","unstructured":"Meng F, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143(3):765\u201376 e1\u20133.","DOI":"10.1053\/j.gastro.2012.05.049"},{"issue":"2","key":"663_CR30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/clinids\/18.2.194","volume":"18","author":"D Torre","year":"1994","unstructured":"Torre D, et al. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis. 1994;18(2):194\u20138.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"663_CR31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","volume":"49","author":"A Lemmers","year":"2009","unstructured":"Lemmers A, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646\u201357.","journal-title":"Hepatology"},{"issue":"3","key":"663_CR32","first-page":"385","volume":"27","author":"L Wang","year":"2011","unstructured":"Wang L, Chen S, Xu K. IL-17 expression is correlated with hepatitis Brelated liver diseases and fibrosis. Int J Mol Med. 2011;27(3):385\u201392.","journal-title":"Int J Mol Med"},{"issue":"1","key":"663_CR33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/mmr.2013.1482","volume":"8","author":"ZB Huang","year":"2013","unstructured":"Huang ZB, et al. HMGB1 release by human liver L02 and HepG2 cells induced by lipopolysaccharide. Mol Med Rep. 2013;8(1):103\u201312.","journal-title":"Mol Med Rep"},{"issue":"12","key":"663_CR34","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1084\/jem.20070247","volume":"204","author":"A Tsung","year":"2007","unstructured":"Tsung A, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007;204(12):2913\u201323.","journal-title":"J Exp Med"},{"issue":"7","key":"663_CR35","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/JVI.70.7.4558-4566.1996","volume":"70","author":"F Su","year":"1996","unstructured":"Su F, Schneider RJ. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol. 1996;70(7):4558\u201366.","journal-title":"J Virol"},{"issue":"6","key":"663_CR36","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"19","key":"663_CR37","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1128\/JVI.76.19.9763-9772.2002","volume":"76","author":"C Tarn","year":"2002","unstructured":"Tarn C, et al. Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. J Virol. 2002;76(19):9763\u201372.","journal-title":"J Virol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0663-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T14:26:35Z","timestamp":1599575195000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0663-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]},"article-number":"310"}}